lamivudine has been researched along with Cirrhosis in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 13 (61.90) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Gao, X; Li, M; Zhao, P; Zhu, S | 1 |
| Alkım, C; Alkım, H; Colak, T; İyisoy, MS; Karayakar, F; Koksal, AR; Sahin, M; Şen, İ; Yetim, A | 1 |
| Liu, D; Liu, X; Ma, J; Ma, N; Wang, Y; Yu, F; Yuan, S; Zhang, X | 1 |
| Calvaruso, V; Craxì, A | 1 |
| Chen, EQ; Tang, H | 1 |
| Bahar, K; Bozdayi, M; Bozkus, Y; Cinar, K; Elhan, A; Idilman, R; Seven, G; Yurdaydin, C | 1 |
| Omata, M; Shiratori, Y; Yoshida, H | 1 |
| de Man, RA; Janssen, HL; Niesters, HG; Sprengers, D; van Gelder, T; Zondervan, PE | 1 |
| Luo, K; Yu, L; Zhu, Y | 1 |
| Barg-Hock, H; Becker, T; Bleck, JS; Bock, CT; Böker, KH; Flemming, P; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Bogaerts, V; Doutreloigne, J; Fan, ST; Hui, CK; Lai, CL; Li, TM; Sablon, E; Wong, BC; Wong, DK; Yuan, HJ; Yuen, MF | 1 |
| Itoh, Y; Kirishima, T; Kunimoto, K; Minami, M; Mori, K; Okanoue, T; Yasui, K | 1 |
| Akarca, US; Batur, Y; Ersoz, G; Gunsar, F; Karasu, Z; Saritas, E; Yuce, G | 1 |
| Blin, P; Degos, F; Deny, P; El Hasnaoui, A; Imbert-Bismut, F; Landais, P; Munteanu, M; Parvaz, P; Poynard, T; Ratziu, V; Slama, A; Thibault, V; Trepo, C; Zoulim, F | 1 |
| Buster, EH; Janssen, HL | 1 |
| Kaczmarski, M; Lebensztejn, DM; Skiba, E; Sobaniec-Łotowska, ME | 1 |
| Ahmed, M; Beranek, P; Brown, D; Burroughs, AK; Dusheiko, G; Elias, E; Grellier, L; Kennedy, F; Kibbler, H; McMaster, P; McPhillips, P; Mutimer, D; Rolles, K | 1 |
| Chan, TM; Cheng, IK; Lai, CL; Lai, KN; Li, FK; Wu, PC | 1 |
| Ben-Ari, Z; Mor, E; Shapira, Z; Tur-Kaspa, R | 1 |
| Lai, CL; Yuen, MF | 1 |
| Chung, YH; Han, JM; Jung, S; Kwon, Y; Lee, HC; Lee, YJ; Lee, YS; Suh, DJ; Yu, E | 1 |
5 review(s) available for lamivudine and Cirrhosis
| Article | Year |
|---|---|
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine | 2014 |
Optimization therapy for the treatment of chronic hepatitis B.
Topics: Antiviral Agents; Disease Progression; DNA, Viral; Drug Therapy, Combination; Fibrosis; Genotype; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunologic Factors; Interferons; Lamivudine; Precision Medicine; Treatment Outcome; Viral Load | 2014 |
Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention.
Topics: alpha-Fetoproteins; Carcinoma, Hepatocellular; Fibrosis; Hepacivirus; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver; Liver Transplantation; Prothrombin; Risk Factors | 2001 |
Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Genotype; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Neoplasms; Nucleosides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors | 2006 |
Treatment of chronic hepatitis B.
Topics: Adjuvants, Immunologic; Antiviral Agents; Drug Therapy, Combination; Fibrosis; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Reverse Transcriptase Inhibitors; Treatment Outcome | 2001 |
2 trial(s) available for lamivudine and Cirrhosis
| Article | Year |
|---|---|
Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrosis; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Male; Middle Aged; Necrosis; Remission Induction; Reverse Transcriptase Inhibitors; Time Factors | 2004 |
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.
Topics: DNA, Viral; Fibrosis; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Failure; Liver Transplantation; Recurrence | 1996 |
14 other study(ies) available for lamivudine and Cirrhosis
| Article | Year |
|---|---|
De novo combination antiviral therapy in e antigen-negative chronic hepatitis B virus-infected paediatric patients with advanced fibrosis.
Topics: Antiviral Agents; Child; DNA, Viral; Female; Fibrosis; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant, Newborn; Interferon-alpha; Lamivudine; Male; Treatment Outcome | 2020 |
Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment.
Topics: Adult; Antiviral Agents; Biopsy; Female; Fibrosis; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Telbivudine; Tenofovir; Trace Elements; Young Adult | 2019 |
Association between gene polymorphisms of IL-28 and response to lamivudine in Chinese rural patients with chronic hepatitis B.
Topics: Adult; Asian People; China; DNA, Viral; Female; Fibrosis; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Interleukins; Lamivudine; Male; Middle Aged; Polymorphism, Single Nucleotide; Reverse Transcriptase Inhibitors; Rural Population; Treatment Outcome | 2013 |
Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
Topics: Adult; Aged; Antibodies, Viral; Antiviral Agents; DNA, Viral; Female; Fibrosis; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Treatment Outcome; Young Adult | 2012 |
[Fatal fibrosing cholestatic hepatitis following renal transplantation].
Topics: Aged; Antiviral Agents; Cholestasis; DNA, Viral; Fatal Outcome; Fibrosis; Hepatitis B; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Viral Load | 2002 |
[Clinical and histological features of fibrosing cholestatic hepatitis].
Topics: Adult; Anti-HIV Agents; Cholestasis, Intrahepatic; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Retrospective Studies | 2002 |
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
Topics: Adenine; Adult; Antiviral Agents; Bacterial Infections; Cholestasis; Drug Resistance, Microbial; Fibrosis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Organophosphonates; Peritonitis; Recurrence; Renal Insufficiency; Reverse Transcriptase Inhibitors | 2003 |
Prognostic factors in severe exacerbation of chronic hepatitis B.
Topics: Adolescent; Adult; Aged; Ascites; Biomarkers; DNA, Viral; Female; Fibrosis; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Prognosis; Promoter Regions, Genetic; Serologic Tests | 2003 |
Lamivudine therapy for Japanese patients with cirrhosis B.
Topics: Carcinoma, Hepatocellular; DNA, Viral; Drug Resistance, Microbial; Fibrosis; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors | 2003 |
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
Topics: Adult; Biomarkers; Biopsy; Female; Fibrosis; Hepatitis C, Chronic; Humans; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors | 2005 |
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
Topics: Adolescent; Antiviral Agents; Biopsy; Child; Female; Fibrosis; Hepatitis B; Humans; Lamivudine; Liver; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; ROC Curve; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2007 |
Treatment of fibrosing cholestatic hepatitis with lamivudine.
Topics: Adult; Cholestasis; DNA, Viral; Female; Fibrosis; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Reverse Transcriptase Inhibitors | 1998 |
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications | 2001 |
Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
Topics: Adult; Biopsy; Cholestasis; Fibrosis; Hepatitis B; Humans; Lamivudine; Liver; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2002 |